7.66
price up icon6.98%   0.50
after-market Handel nachbörslich: 7.65 -0.010 -0.13%
loading

Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten

pulisher
02:08 AM

What drives Emergent BioSolutions Inc. stock priceHigh-velocity capital appreciation - Autocar Professional

02:08 AM
pulisher
12:07 PM

Is Emergent BioSolutions Inc. a good long term investmentFree Market Dynamics Reports - jammulinksnews.com

12:07 PM
pulisher
06:03 AM

Emergent BioSolutions Inc. Stock Analysis and ForecastBreakthrough profit margins - jammulinksnews.com

06:03 AM
pulisher
Jul 20, 2025

Is MDU Resources Group Inc. a good long term investmentHigh-yield investments - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

AGYS Stock Analysis and ForecastAccelerated financial growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Emergent BioSolutions Inc. stockFree Investment Community - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Hawthorn Bancshares Inc. Stock Analysis and ForecastBreakthrough capital growth - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What drives EMX Royalty Corporation stock priceSkyrocketing returns - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 17, 2025

Emergent Signs $174M Manufacturing Deal For AstraZeneca’s Covid-19 Candidate - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

What makes Emergent BioSolutions Inc. stock price move sharplyPotential Rocket List - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Lobbying Update: $440,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed - Quiver Quantitative

Jul 16, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions to Report Second Quarter 2025 Financial Re - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions Inc. to Host Q2 2025 Financial Results Conference Call on August 6 - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions Q2 2025 Earnings Call Scheduled for August 6: Key Details Inside - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025 - TradingView

Jul 15, 2025
pulisher
Jul 14, 2025

Government Contract Update: $52M payment to EMERGENT BIOSOLUTIONS CANADA INC - Nasdaq

Jul 14, 2025
pulisher
Jul 10, 2025

Emergent BioSolutions signs contract modification award for CNJ-016 - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 10, 2025
pulisher
Jul 10, 2025

Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛

Jul 10, 2025
pulisher
Jul 09, 2025

Emergent BioSolutions stock rises on government contract modification - Investing.com India

Jul 09, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Stock Rises After New US Order For Smallpox Complication Therapy - Stocktwits

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions secures contract modification for smallpox treatment By Investing.com - Investing.com South Africa

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions secures contract modification for smallpox treatment - Investing.com Australia

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions (EBS) Expands Smallpox Vaccine Contract wi - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions (EBS) Secures Smallpox Preparedness Contra - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Gets $51.9 Million Contract Modification for Smallpox Preparedness - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions stock rises on government contract modification By Investing.com - Investing.com Canada

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts - The Manila Times

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Secures Contract Modification for Additional VIGIV Doses to Support U.S. Smallpox Preparedness - Quiver Quantitative

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Strengthens US Biodefense Arsenal with $51.9M Government Contract - Stock Titan

Jul 08, 2025
pulisher
Jul 07, 2025

Lobbying Update: $40,000 of EMERGENT BIOSOLUTIONS lobbying was just disclosed - Quiver Quantitative

Jul 07, 2025
pulisher
Jul 05, 2025

Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? - simplywall.st

Jul 05, 2025
pulisher
Jul 03, 2025

Emergent BioSolutions adds KLOXXADO to online naloxone platform By Investing.com - Investing.com India

Jul 03, 2025
pulisher
Jul 02, 2025

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® ( - GuruFocus

Jul 02, 2025
pulisher
Jul 02, 2025

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate - The Manila Times

Jul 02, 2025
pulisher
Jun 30, 2025

Investors Can Still File Late Claims in Emergent BioSolutions Settlement - TradingView

Jun 30, 2025
pulisher
Jun 29, 2025

Emergent BioSolutions Inc.(NYSE: EBS) added to Russell 3000E Value Index - MarketScreener

Jun 29, 2025
pulisher
Jun 25, 2025

Is Emergent BioSolutions, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

Emergent BioSolutions secures $62.4 million contract for botulism antitoxin By Investing.com - Investing.com South Africa

Jun 24, 2025
pulisher
Jun 23, 2025

Emergent BioSolutions Awarded $62.4 Million Contract Modification for BAT® Antitoxin by U.S. Department of Health and Human Services - Quiver Quantitative

Jun 23, 2025
pulisher
Jun 20, 2025

Emergent BioSolutions Announces Addition to Russell 3000® Index - The Manila Times

Jun 20, 2025
pulisher
Jun 20, 2025

Emergent BioSolutions to join Russell 3000 Index after market close June 27 - Investing.com

Jun 20, 2025
pulisher
Jun 19, 2025

EBS Stock Up 1.4% after 1-Day Win Streak - Trefis

Jun 19, 2025
$73.31
price up icon 1.34%
$15.02
price up icon 0.60%
$9.37
price up icon 1.41%
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 1.32%
$133.66
price up icon 0.69%
$305.61
price up icon 2.59%
Kapitalisierung:     |  Volumen (24h):